Yusuf Yılmaz(@ProfYusufYilmaz) 's Twitter Profile Photo

Delighted to be a part of the Global NAFLD Nomenclature Steering Committee alongside distinguished colleagues. Honored to have over 120 publications in this field. Looking forward to contributing to and furthering the progress in , , , and…

Delighted to be a part of the Global NAFLD Nomenclature Steering Committee alongside distinguished colleagues. Honored to have over 120 publications in this field. Looking forward to contributing to #NAFLD and furthering the progress in #EASLcongress, #SLD, #MASLD, and…
account_circle
stephen barclay(@stephentbarclay) 's Twitter Profile Photo

CAMARO, RCT MMF Vs Aza to induce remission. Higher remission in MMF, similar AE rates, ⬆️ discontinuations in AZA group. Nausea most common reason for discontinuation. Great data - will it change practice/guidelines? Effective contraception if appropriate a must

CAMARO, RCT MMF Vs Aza to induce remission. Higher remission in MMF, similar AE rates, ⬆️ discontinuations in AZA group.  Nausea most common reason for discontinuation. Great data - will it change practice/guidelines? Effective contraception if appropriate a must #EASLCongress
account_circle
Manas Vaishnav(@Being_Medico) 's Twitter Profile Photo

Had good opportunity to present our short course terlipressin trial in AVB🩸at . Also presented poster on further decompensation after AVB.
Thanks to team lead by Shalimar for all the guidance AIIMS, New Delhi abhinav anand Sagnik Biswas Anshuman Elhence
EASLnews

Had good opportunity to present our short course terlipressin trial in AVB🩸at #EASLCongress. Also presented poster on further decompensation after AVB.
Thanks to team lead by @drshalimar for all the guidance @aiims_newdelhi @abhinav_anand28 @JustSagnik @elhence_anshu 
@EASLnews
account_circle
Jenny Towey(@liver_dietitian) 's Twitter Profile Photo

Grateful to have chaired an important session this morning at with passionate colleagues who shared knowledge on supporting Nutrition Impact Symptoms to Optimise Nutrition in liver disease. Your pt can not eat if they have barriers which are not managed first!

Grateful to have chaired an important session this morning at #EASLCongress with passionate colleagues who shared knowledge on supporting Nutrition Impact Symptoms to Optimise Nutrition in liver disease. Your pt can not eat if they have barriers which are not managed first!
account_circle
Nikolaj Torp(@NikolajTorp_) 's Twitter Profile Photo

. LIVERHOPE phase III trial at Late Breaker w/Elisa Pose summarized 🔽

👨 >200 cirrhosis pts Child-Pugh B-C (<12)
💊 rifaximin + simvastatin vs. placebo
🎯 time-to-ACLF within 1 year

❌ did not meet primary endpoint of effect on ACLF development

. @LiverHope_h2020 phase III trial at #EASLCongress Late Breaker w/Elisa Pose summarized 🔽

👨 >200 cirrhosis pts Child-Pugh B-C (<12)
💊 rifaximin + simvastatin vs. placebo
🎯 time-to-ACLF within 1 year

❌ did not meet primary endpoint of effect on ACLF development
account_circle
Susana Rodrigues(@RodriguesSu24) 's Twitter Profile Photo

Annalisa Berzigotti⁩ presents data on a meta-analysis on post-banding ulcer bleeding. High mortality ~22%! Well done Maria Brito, Matthias Knecht, ⁦jaumebosch⁩ and Reiner Wiest!! Universität Bern⁩ ⁦Insel Gruppe

⁦@docberza⁩ presents data on a meta-analysis on post-banding ulcer bleeding. High mortality ~22%! Well done Maria Brito, Matthias Knecht, ⁦@jaumebosch9⁩ and Reiner Wiest!! #EASLCongress ⁦@unibern⁩ ⁦@inselgruppe⁩
account_circle
Miki Scaravaglio(@MScaravaglio) 's Twitter Profile Photo

✅Preliminary data on impact of PEs exposure on the progression of PLD cysts
👉🏼confirmation needed
Thank you to my colleagues
Antonio Ciaccio 🧠 of this project
Martina Manna our fantastic datamanager 👩🏻‍💻
Thank you to our ❤️ PLD patients HSG Gastro

✅Preliminary data on impact of PEs exposure on the progression of PLD cysts 
👉🏼confirmation needed
Thank you to my colleagues
@ciaccio_  🧠 of this project
@MartinaManna93 our fantastic datamanager 👩🏻‍💻
Thank you to our ❤️ PLD patients #EASLcongress @HSG_Gastro
account_circle
Sophie Allen(@Sophie_L_Allen) 's Twitter Profile Photo

It’s day 2 of and poster day! If you’re interested in learning more about sarcopenia in end-stage liver disease please come by poster 370 during todays poster sessions!

It’s day 2 of #EASLCongress and poster day! If you’re interested in learning more about sarcopenia in end-stage liver disease please come by poster 370 during todays poster sessions!
account_circle
Una Rastovic(@UnaRastovic) 's Twitter Profile Photo

Cure ? Say no more! Very proud to present this work on antifibrotic effect of cyclophilin inhibition at ! Thanks to EASLnews EASL Education for the YI bursary that enabled me to be there in person!
ElePalma Chokshi Lab London Urbani Lab Sara Campinoti

Cure #fibrosis? Say no more! Very proud to present this work on antifibrotic effect of cyclophilin inhibition at #EASLCongress! Thanks to @EASLnews @EASLedu for the YI bursary that enabled me to be there in person! 
@DrElePalma @ChokshiLab @UrbaniLab @Sara_Campinoti #LiverTwitter
account_circle
Angelo Armandi(@AngeloArmandi) 's Twitter Profile Photo

Happy to present at the interim results on our study on 100 Hz measurement in a multi-center cohort of biopsied patients for the detection of advanced ! Great perspectives!! Luca Miele Jörn Schattenberg Manuel Romero-Gómez

Happy to present at #EASLcongress #EASL2023 the interim results on our study on 100 Hz #spleen #stiffness measurement in a multi-center cohort of biopsied #NAFLD patients for the detection of advanced #fibrosis! Great perspectives!! @lmiele74 @schattenbergJ @mromerogomez
account_circle
Salvatore Piano(@salvatore_piano) 's Twitter Profile Photo

Results of the LIVERHOPE trial presented at

✅Simvastatin + rifaximin vs placebo in decompensated cirrhosis:

❌ no difference in
❌ no difference in survival
❌ no difference in complications

⚠️rhabdomiolysis in simvastatin/rifaximin arm

EASLnews

Results of the @LiverHope_h2020 trial presented at #EASLCongress

✅Simvastatin + rifaximin vs placebo in decompensated cirrhosis:

❌ no difference in #ACLF 
❌ no difference in survival
❌ no difference in complications

⚠️rhabdomiolysis in simvastatin/rifaximin arm

@EASLnews
account_circle
Vivian Ortiz(@VivianOrtizMD) 's Twitter Profile Photo

Transplant oncology session with intriguing topics
🔸️Neoadjuvant therapy pre transplant
🔸️Role of immune check pt inhibitors
🔸️Transplant for cholangiocarcinoma➕️metastatic Colorectal cancer
Best part: catching up with Julie Heimbach➕️David James Pinato 🇺🇦
afterwards.

Transplant oncology session with intriguing topics
🔸️Neoadjuvant therapy pre transplant
🔸️Role of immune check pt inhibitors
🔸️Transplant for cholangiocarcinoma➕️metastatic Colorectal cancer
Best part: catching up with @JulieHeimbach➕️@DJPinato
afterwards. #EASLCongress
account_circle